<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896552/" ref="ordinalpos=1628&amp;ncbi_uid=2682424&amp;link_uid=PMC2896552" image-link="/pmc/articles/PMC2896552/figure/F2/" class="imagepopup">Figure 2.  From: The Phosphoinositide 3-Kinase Inhibitor PI-103 Downregulates Choline Kinase ? Leading to Phosphocholine and Total Choline Decrease Detected by Magnetic Resonance Spectroscopy. </a></div><br /><div class="p4l_captionBody">Molecular effects of inhibition with PI-103 on the PI3K signaling pathway in PTEN null PC3 prostate and PIK3CA mutant HCT116 colon carcinoma cell lines. A, representative Western blots showing decreases in molecular biomarkers in the PI3K signaling pathway in PC3 prostate cancer cells following treatment with PI-103 at 1×, 2.5×, and 5× GI50, 24 h posttreatment. B, representative Western blots showing decreases in molecular biomarkers in the PI3K signaling pathway in PC3 prostate cancer cells at selected time points posttreatment with PI-103 (5× GI50). C, representative Western blots showing inhibition of molecular biomarkers in the PI3K signaling pathway and changes in protein expression levels of enzymes involved in lipid metabolism in HCT116 colon cancer cells following treatment with PI-103 (5× GI50).</div></div>